Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity. [electronic resource]
Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity. [electronic resource] — المؤلف: Evans, I — Aug 1977
- المؤلف
- Evans, I
- النشر
- Aug 1977
- الوصف
- 151-5 p.
- الموضوعات
- Bromodeoxyuridine؛ Cell Division؛ Cell Line؛ Dose-Response Relationship, Drug؛ Hydrogen-Ion Concentration؛ Peptide Hydrolases؛ Thymidine